GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Median PS Value

Cleo Diagnostics (ASX:COV) Median PS Value : A$0.00 (As of May. 23, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Cleo Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$. Cleo Diagnostics's 10-Year median PS Ratio is . Therefore, the Median PS Value for today is A$0.00.

As of today (2024-05-23), Cleo Diagnostics's share price is A$0.17. Cleo Diagnostics's Median PS Value is A$0.00. Therefore, Cleo Diagnostics's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Cleo Diagnostics's Median PS Value or its related term are showing as below:

ASX:COV's Price-to-Median-PS-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.8
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Cleo Diagnostics Median PS Value Historical Data

The historical data trend for Cleo Diagnostics's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Median PS Value Chart

Cleo Diagnostics Annual Data
Trend Jun23
Median PS Value
-

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23
Median PS Value - - -

Competitive Comparison of Cleo Diagnostics's Median PS Value

For the Medical Devices subindustry, Cleo Diagnostics's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cleo Diagnostics's Price-to-Median-PS-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Price-to-Median-PS-Value falls into.



Cleo Diagnostics Median PS Value Calculation

Cleo Diagnostics's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=*
=

10-Year Median PS Ratio is .
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cleo Diagnostics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cleo Diagnostics  (ASX:COV) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Cleo Diagnostics's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.17/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cleo Diagnostics Median PS Value Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cleo Diagnostics (ASX:COV) Business Description

Traded in Other Exchanges
N/A
Address
480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines